Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP801713.RAlYJwPaxhBU2PJaIzuYHiXIE3CjUd2gCAjd7ymY5fYvI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP801713.RAlYJwPaxhBU2PJaIzuYHiXIE3CjUd2gCAjd7ymY5fYvI130_assertion type Assertion NP801713.RAlYJwPaxhBU2PJaIzuYHiXIE3CjUd2gCAjd7ymY5fYvI130_head.
- NP801713.RAlYJwPaxhBU2PJaIzuYHiXIE3CjUd2gCAjd7ymY5fYvI130_assertion description "[Indeed, combination of intratumor injections of mouse IFN-? and intraperitoneal injections of anti-CD137 mAb synergized as seen on subcutaneous lesions derived from the MC38 colon carcinoma, which is resistant to each treatment if given separately.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP801713.RAlYJwPaxhBU2PJaIzuYHiXIE3CjUd2gCAjd7ymY5fYvI130_provenance.
- NP801713.RAlYJwPaxhBU2PJaIzuYHiXIE3CjUd2gCAjd7ymY5fYvI130_assertion evidence source_evidence_literature NP801713.RAlYJwPaxhBU2PJaIzuYHiXIE3CjUd2gCAjd7ymY5fYvI130_provenance.
- NP801713.RAlYJwPaxhBU2PJaIzuYHiXIE3CjUd2gCAjd7ymY5fYvI130_assertion SIO_000772 20309938 NP801713.RAlYJwPaxhBU2PJaIzuYHiXIE3CjUd2gCAjd7ymY5fYvI130_provenance.
- NP801713.RAlYJwPaxhBU2PJaIzuYHiXIE3CjUd2gCAjd7ymY5fYvI130_assertion wasDerivedFrom befree-2016 NP801713.RAlYJwPaxhBU2PJaIzuYHiXIE3CjUd2gCAjd7ymY5fYvI130_provenance.
- NP801713.RAlYJwPaxhBU2PJaIzuYHiXIE3CjUd2gCAjd7ymY5fYvI130_assertion wasGeneratedBy ECO_0000203 NP801713.RAlYJwPaxhBU2PJaIzuYHiXIE3CjUd2gCAjd7ymY5fYvI130_provenance.